Clinical Research Facility

Farmington, New Mexico 87401

We've found

5 trials

at this facility

A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer

Status: Enrolling
Updated: 2/15/2013

from

Farmington, NM

Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma

Status: Enrolling, Phase III
Updated: 11/2/2015

from

Farmington, NM

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Farmington, NM

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Status: Enrolling, Phase IV
Updated: 11/2/2015

from

Farmington, NM

A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Farmington, NM

Use our guide to learn which trials are right for you!